SKKAF yields 1.21% · JNJ yields 2.13%● Live data
📍 SKKAF pulled ahead of the other in Year 1
Combined, SKKAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKKAF + JNJ for your $10,000?
Sk Kaken Co.,Ltd. manufactures and sells organic and inorganic water-based coating materials, synthetic resin paints, inorganic coating materials, and inorganic building materials in Japan and internationally. It is also involved in the contracting of special finishing works and fireproof insulation works; and manufacture and sale of heat insulation materials, fireproof coating materials, and fireproof paints, as well as various chemical products. In addition, the company's products include exterior finishes, top coating materials, interior finishes, roof paints, iron paints, floor coverings, rooftop waterproofing materials, base adjustment coating materials, fireproof coating/insulation materials. The company was formerly known as Shikoku Kaken Industry Co., Ltd. and changed its name to Sk Kaken Co.,Ltd. in April 1991. Sk Kaken Co.,Ltd. was founded in 1955 and is headquartered in Ibaraki, Japan.
Full SKKAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.